Vogichem M 500mg/0.3mg Tablet SR
Marketer
Swastik Life Sciences
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Vogichem M 500mg/0.3mg Tablet SR
Vogichem M 500mg/0.3mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, Vogichem M is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications significantly impact diabetes control. Potential side effects include gastrointestinal upset (nausea, altered taste, anorexia, flatulence, abdominal pain, diarrhea), and skin rash; these are generally transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention. Your physician can provide management strategies for any bothersome side effects. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess hematological parameters and liver function, are recommended.
Uses of Vogichem M 500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vogichem M 500mg/0.3mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogichem M 500mg/0.3mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Vogichem M 500mg/0.3mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Vogichem M 500mg/0.3mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Vogichem M 500mg/0.3mg Extended-Release Tablets should be administered with a meal.
How Vogichem M 500mg/0.3mg Tablet SR works:
Vogichem M 500mg/0.3mg extended-release tablets contain a dual-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Vogichem M 500mg/0.3mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Vogichem M 500mg/0.3mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vogichem M tablets (500mg/0.3mg) are likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk with a risk of infant harm.
DrivingSAFE
Extended-release Vogichem M 500mg/0.3mg tablets typically do not impair driving ability. Nevertheless, individuals using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, or repaglinide, should be aware of the potential for low blood sugar.
KidneyCAUTION
Exercise caution when administering Vogichem M 500mg/0.3mg Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Vogichem M 500mg/0.3mg Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Vogichem M 500mg/0.3mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Vogichem M 500mg/0.3mg Tablet SR :
Should you forget a dose of Vogichem M 500mg/0.3mg Extended-Release Tablet, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogichem M 500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently